Mycobacterial Diseases

Mycobacterial Diseases
Open Access

ISSN: 2161-1068

+44 1478 350008

Research Article - (2018) Volume 8, Issue 3

Molecular Diversity and Homology in Six CFPs Genes in the Novel BioType, 'Indian Bison Type' of Mycobacterium avium subspecies paratuberculosis of Goat Origin vs. other Biotypes

Singh SV1*, Chaubey KK1,2, Kumaresan G1, Gupta RD3, Bhatia AK2, Rathore AS3, Gupta S1 and Singh M1
1Animal Health Division, Central Institute for Research on Goats, Mathura, Uttar Pradesh, India
2Department of Microbiology and Immunology, GLA University, Mathura, Uttar Pradesh, India
3Department of Life Sciences and Biotechnology, South Asian University, New Delhi, India
*Corresponding Author: Singh SV, Animal Health Division, Central Institute for Research on Goats, Mathura, Uttar Pradesh, India, Tel: +91 565 2763260; +91 9719072856, Fax: +91 565 2763246 Email:

Keywords: Mycobacterium avium subspecies paratuberculosis; Molecular diversity; Homology; CFPs; Indian bison type; Phylogenetic tree analysis; Sequence identity plot

Highlights

Characterization of Mycobacterium avium subspecies paratuberculosis (MAP) ‘S5’ Indian Bison Type strain was done through six MAP cultural filtrate proteins (CFPs) genes (MAP 1693c, MAP 2168c, MAP Mod D, MAP 85c, MAP Pep AN and MAP Pep ACN) which are responsible for encoding six recombinant CFPs.

This study will help to understand the molecular diversity and homology of MAP CFPs genes of MAP ‘S5’ with other available strains.

Mutations can lead to modulations in the functions of the MAP metabolism thereby influencing the virulence and the host response to the disease.

Introduction

Mycobacterium avium subspecies paratuberculosis (MAP) is not only highly pathogenic but also has widest host range infecting domestic livestock species, wild ruminants, other animals, non-human primates and human beings [1-4]. Potential involvement of MAP in human diseases has significant concerns for public health [5]. MAP bacilli has been recovered from intestinal biopsies from patients suffering from Crohn’s disease, an incurable inflammatory enteritis that affects lower sections of small intestine and colon. Similarly other workers have also reported involvement of MAP in clinical symptoms and gross pathology of Crohn’s disease (CD) in human beings and Johne's disease in animals [6-8]. In India, MAP has also been recovered from chronic patients of CD [9], suspected animal workers [10], human population from peri-urban areas [11], mass screening of human samples [1] and of patients suffering with advance clinical stage of CD [12].

In taxonomic classification, MAP has been placed under Order- Actinomycetes, Family- Mycobacteriaceae and Genus-Mycobacterium . Turenne et al. [13] reported 130 species and subspecies under single genus Mycobacterium . Generally, majority of the species and subspecies are non-pathogenic except some successful pathogens, which are closely related with soil bacteria like Actinomyces and Streptomyces [14,15]. MAP is a non-motile, acid-fast, aerobic rod shaped bacteria having complex and lipid-rich cell wall. Genetically, MAP is almost indistinguishable to M. avium subspecies avium (MAA) because they share 95.0% of their genes and exhibited more than 99.0% of homologies [16]. While sharing many genetic similarities with MAA , the phenotypic characteristics of MAP is different to MAA , with reports [17] observing MAP is less closely linked to mycobacteria from Mycobacterium tuberculosis complex and Mycobacterium leprae . Complete sequencing of genome of MAP K10 'Cattle Type' and MAP 'S5 ' Indian Bison Type [18] have led to many inroads into the MAP biology. Current information on the complete genomes of 'K10' and ‘S5’ strains indicated that size of MAP was 4.83 Mb and 4.79 Mb, respectively. MAP genome has 4350 protein-coding sequences including 3223 conserved proteins with known functions and 1088 conserved proteins with un-known functions and with 39 proteins with unique identity [19].

MAP ‘S5’ ‘Indian Bison Type’ biotype was isolated from a terminally sick goat of Jamunapari breed at ICAR-Central Institute for Research on Goats, Makhdoom, Mathura, UP, India. This strain has been characterized as recently evolved MAP biotype [20]. 'S5' strain of goat origin, is the source of antigens for 'Indigenous ELISA kit' and 'indigenous vaccine' for all 4 domestic livestock species [21,22]. Whole genome sequencing of MAP ‘S5’ strain was carried out to explore genetic organization and genes involved in physiology, pathogenicity and immunogenicity. This 'Whole Genome Shotgun' project has been deposited at DNA Data Bank of Japan, Mishima, Japan. (DDBJ)/ EMBL Nucleotide Sequence Database, Cambridge, UK. (EMBL)/ GenBank, NCBI, Bethesda, MD, USA. (Genbank) under accession number ANPD00000000. The version described in this paper is the first version, ANPD01000000 [18].

Secretary/culture filtrate proteins (CFPs) were considered highly immunogenic and immune-dominant due to their presence in the extracellular environment where they are more likely to encounter sensitized immune cells. This was confirmed in a study comparing CFPs from supernatants and antigens of intracellular origin [23]. Comparing the CFPs with cellular proteins showed greater seroreactivity in animals infected with MAP [24]. Serum from infected cattle was used for immune-blot analysis, which showed that infected sera reacted more strongly to CFPs as compared to antigens of intracellular origin [25]. Sensitivity of sero-diagnostic tests improved with use of CFPs, and similarly for other mycobacterial pathogens, like M. bovis and M. tuberculosis [26-29]. Use of CFPs in ELISA increased sensitivity by 25.0% over 'commercial ELISAs' in low shedder animals [30]. Hence, CFPs are focus of research for DIVA based diagnostics and vaccine development. A range of new important CFPs have been identified using new technologies like 2D gel electrophoresis, chromatography, mass spectrometry and peptide mass fingerprint. Currently, semi-purified protoplasmic antigens (sPPA) are used for sero-diagnostics. More detailed categorization of antigen framework of MAP will be important to develop improved diagnostics. Cho et al. (2006) identified 14 CFPs of MAP JTC303 by immunoblot and mass spectrometry. Polyclonal rabbit antibodies (Rabbit anti-M. paratuberculosis JTC303) applied were directed against these 14 proteins where it reacted only with five CFPs (MAP 1693c, MAP 2168c, MAP Mod D, MAP 85c, MAP Pep A (Two subunit: MAP Pep AN and MAP Pep AC ).

Present study aimed to characterize MAP ‘S5’ Indian Bison Type strain through these six MAP secretome genes (MAP 1693c, MAP 2168c, MAP Mod D, MAP 85c, MAP Pep AN and MAP Pep AC ) which are responsible for encoding six recombinant secretory proteins of MAP.

Materials and Methods

Location of work

The study was conducted at Central Institute for Research on Goats, Makhdoom, and South Asian University, New Delhi, in India. Six MAP CFPs had encouraging sero-diagnostic values. Sequences of all six genes of novel 'Indian Bison Type' biotype of MAP (strain S5) of goat origin were amplified by PCR and cloning of all six genes was done in expression vectors pET28a (+)/pET22b (+). All Clones were amplified in E. coli cloning strain; XL1-Blue Competent Cells (Stratagene, Agilent) or, XL10-Gold Ultracompetent Cells (Stratagene, Agilent).

Cloning procedure and confirmation of orfs by sequencing

Six immunogenic MAP CFPs genes (1693c, 2168c, ModD, 85c, Pep AN and Pep AC ) (Supplementary Figure 1) were cloned, since these genes express proteins which react with serum samples from animals infected with MAP (Table 1) [24].

S.NO Name of CFPs Putative Function Gene Size
1 MAP 1693c Peptidyl-prolylcis–trans isomerase 474 bp
2 MAP 2168c Hypothetical protein 453bp
3 MAP ModD Fibronectin attachment 998 bp
4 MAP 85 C Mycolyltransferase 999 bp
5 MAP Pep AN Serine proteinase 423 bp
6 MAP Pep AC Serine proteinase 540 bp

Table 1: Short listing of potential antigens in Secretome of MAP .

CFPs genes were successfully amplified from MAP ‘S5’ genomic DNA using specific primers (Table 2) in thermal conditions with initial denaturation at 94C for 5 mins followed by 37 cycles of denaturation at 94°C for 30 sec, Annealing (64°C for 1693C , 66°C for 2168C , 54°C for ModD , 68°C for 85C and 58°C for PepAN and AC) for 1 min and extension at 72°C for 5 min followed by final extension of 72°C for 5 min). Purification of PCR products was done using gel extraction purification kit (GeneJet plasmid miniprep kit, Cat. No. K0502, Thermo fisher scientific, USA). Easy cloning pJET1.2/blunt vector (CloneJET PCR Cloning kit, Cat. no.: #K1231, Thermo fisher Scientific), pTZ57R/T Cloning vector (InsTAclone PCR Cloning Kit, Cat. no.: #1214, Thermo fisher Scientific, USA) and expression vector, pET-28a (+) and pET-22b (+) were used. Both expression vectors contained a T7 promoter and C-terminal 6X His-tag coding sequence of multiple cloning regions.

S.No MAP Gene name Oligos Name Direction Sequence Restriction
Enzyme
Product
Length
Reference
1 MAP 1693c MAP 1693c.28a.FP Forward 5’- GAA TTC ATG GCC GAC TCC TGC CCG ACC GCC -3’ EcoRI 474 bp In-house designed
MAP 1693c.28a.RP Reverse 5’- CTC GAG CTA GGT CGT GGC GCC GAG GAT C -3’ XhoI
2 MAP 2168c MAP 2168c.28a.FP Forward 5’- GAA TTC ATG GCA GCG CCG ACC GGT CTG C -3’ EcoRI 453 bp In-house designed
MAP 2168c.28a.RP Reverse 5’- CTC GAG TCA GTT CAT CGC GGT GGC CGC C -3’ XhoI
3 MAP Mod D MAP Mod D.22b.FP Forward 5’- CAT ATG GAT CCC GAG GTC CCG ACC -3’ NdeI 998 bp Cho et al., 2007
MAP Mod D.22b.RP Reverse 5’- CTC GAG GGC CGA GAG GGT CTG CTG C-3’ XhoI
4 MAP 85 C MAP 85c.28a.FP Forward 5’- GGA TCC ATG GCG GGT GGC TCC CCC GTC -3’ BamHI 999 bp In-house designed
MAP 85c.28a.RP Reverse 5’- AAG CTT TCA GGT GGC GGG CTG GGC C -3’ HindIII
5 MAP Pep AN MAP Pep AN.28a.FP Forward 5’- GGA TCC ATG GCA CCG TCG GGC CTG GC -3’ BamHI 423 bp In-house designed
MAP Pep AN.28a.RP Reverse 5’- CTC GAG TCA GAC GAC CTT GCC GGC CAC C -3’ XhoI
6 MAP Pep AC MAP Pep AC.28a.FP Forward 5’- GGA TCC ATG GCG CTC AAC CAG AGC GTC -3’ BamHI 540 bp In-house designed
  MAP Pep AC.28a.RP Reverse 5’- CTC GAG TCA GGC CGG CGG CCC CTC C -3’ XhoI

Table 1: Short listing of potential antigens in Secretome of MAP.

Purified PCR products were ligated to pJET1.2/blunt vector or, pTZ57R/T cloning vector as per manufacturer’s protocols. Recombinant clones were transformed into competent E.coli XL-1/ XL-10. After sequencing, the inserted ORFs were cloned into sites for directional ligation into the pET-28a (+) or, pET-22b (+) vector after digestion with specific restriction enzymes. Ligated products were transformed into XL-1/XL-10 competent cells followed by plating on kanamycin (pET28a vector)/ampicillin (pET22b vector) containing LB agar and incubated at 37°C for 12-18 h. We observed kanamycin/ ampicillin resistant colonies of transformed cells containing respective ligated vector compared to control empty vector. Six to ten colonies were selected from respective transformed plates and cloned products were confirmed by colony PCR. Colony PCR confirmed transformed colonies of respective transformants were cultured in LB media containing respective antibiotics followed by mini preparation of plasmid DNA. Plasmid DNA of corresponding clones were confirmed by digestion with respective restriction enzymes (Table 3) indicating successful cloning of the gene of interest.

Sn MAP CFPs Gene Easy Cloning Restriction
Enzyme
Cloning in Expression Vectors
Vector/ Kit   Antibiotics and Supplements Cells used in Transformation Expression Vectors Cells used in Transformation
1 MAP 1693c pJET1.2/blunt vector,
CloneJET PCR Cloning kit (#K1231)
Tetracyline (20 µg/ml) XL-1-Blue competent cells EcoRI pET28a(+) expression vector XL-1-Blue competent cells
XhoI
2 MAP 2168c pJET1.2/blunt vector,
CloneJET PCR Cloning kit (#K1231)
Tetracyline (20 µg/ml) XL-1-Blue competent cells EcoRI pET28a(+) expression vector XL-1-Blue competent cells
XhoI
3 MAP Mod D pTZ57R/T Cloning vector, InsTAclone PCR Cloning Kit (#1214) Tetracycline (20 µg/ml), X-gal (20 µg/ml) and IPTG (20 µg/ml) XL-10 Ultracompetent cells NdeI pET22b(+) expression vector XL-10 Ultracompetent cells
XhoI
4 MAP 85c pTZ57R/T Cloning vector, InsTAclone PCR Cloning Kit (#1214) Tetracycline (20 µg/ml), X-gal (20 µg/ml) and IPTG (20 µg/ml) XL-10 Ultracompetent cells BamHI pET28a(+) expression vector XL-10 Ultracompetent cells
HindIII
5 MAP Pep AN pJET1.2/blunt vector,
CloneJET PCR Cloning kit (#K1231)
Tetracyline (20 µg/ml) XL-1-Blue competent cells BamHI pET28a(+)
expression vector
XL-10 Ultracompetent cells
XhoI
6 MAP Pep AC pJET1.2/blunt vector,
CloneJET PCR Cloning kit (#K1231)
Tetracyline (20 µg/ml) XL-1-Blue competent cells BamHI pET28a(+) expression vector XL-10 Ultracompetent cells
XhoI

Table 3: Details of Cloning and expression vector and kits, restriction enzyme used in this study.

In order to cross-check the cloned gene of interest, plasmid DNA of each clone were sequenced using T7 universal primer to obtain the inframe gene of insert into the expression vector (pET28a/ pET22b). All the six purified cloned plasmids were transformed into E. coli Rosetta cells to evaluate expression of r-CFPs. Optimum r-CFPs production was observed at 0.3 mM IPTG concentration, 24°C-37°C temperature and 16-30 h of incubation and all expressed r-CFPs was purified using Ni-NTA resin and confirmed by SDS-PAGE (Figure 1). The whole process of cloning and expression of CFPs was presented in a schematic flow chart (Figure 2).

mycobacterial-diseases-Purified-expressed

Figure 1: Purified expressed recombinant CFPs (Right to left): Lane M=Pre-stained page ladder (#SM0671), Lane 1=MAP 1693c purified protein, Lane 2=MAP 2168c purified protein, Lane 3=MAP Mod D purified protein, lane 4=MAP 85c purified protein, lane 5=MAP Pep AN purified protein, Lane 6=MAP Pep AC purified protein.

mycobacterial-diseases-Cloning

Figure 2: A schematic flow chart of the whole process (Cloning, expression and evolutionary analysis using constructions of Sequence identity Plot and Phylogenetic tree analysis).

Evolutionary analyses

Phylogenetic tree construction of six MAP secretary/CFPs genes including (MAP 1693c, MAP 2168c, MAP Mod D, MAP 85c, MAP Pep AN and MAP Pep ACN ) of MAP ‘S5’ Indian Bison Type strain was done using MEGA6 software [31]. Evolutionary history was inferred using the Minimum Evolution method [32,33].The percentage of replicate trees in which the associated taxa were clustered together by bootstrapping analysis (500 replicates). The tree was drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Maximum Composite Likelihood method [34] and are in the units of the number of base substitutions per site. The ME tree was searched using the Close-Neighbor- Interchange (CNI) algorithm [35]. The Neighbor-joining algorithm [36] was used to generate the initial tree. Submission of sequence data of all genes sequences generated during the current study for MAP S5 CIRG Bison type (MAP 1693c, MAP 2168c, MAP Mod D, MAP Pep AN and MAP Pep AC) were aligned and submitted to the Genbank™ with the accession numbers MG753462, MG753463, MG753464, MG753465, MG753466 and MG753467, respectively (Supplementary Figures 8-13).

The whole process of cloning, expression and evolutionary analysis (Sequence Identity Plot and Phylogenetic tree analysis) of all six MAP CFP gene sequences were portrayed in a schematic flow chart (Figure 2).

Results

All six MAP CFPs were expressed and purified and their molecular weight (kDa) were verified by SDS-PAGE (Figure 1). Six MAP CFP genes were sequenced and analyzed using Sequence Identity plot and Phylogenetic tree analysis.

A sequence identity plot was constructed for MAP 1693c secretome for Indian bison type strain of CIRG (Indian Bison CIRG or, Indian Bison/CIRG), MAP K10 (MAP K10 AE016958.1), MAP/TANUVAS (MAP/TANUVAS/TN/India/2008 CPO 15495.1), MAP 4 (MAP 4 CP005928.1 positions 169), MAP E93 (MAP E93_CP010114.1 Position 1), MAP FDAARGOS_305 (MAP FDAARGOS_305_CP022095.1 Po), MAP JII-1961 (MAP JII-1961) and MAP E1 (MAP E1_CP010113.1 Positions 16) standard reference stain. There were five nucleotide (nt) deletions (CCACC) found in MAP K10, MAP/TANUVAS, MAP JII-1961 at nucleotide position 100 to 104. Similarly, at nt154 to nt156 position, there was three nucleotide (AGA) deletion in MAP K10, MAP/TANUVAS and MAP JII-1961 while the deletions were absent in Indian Bison CIRG, MAP 4, MAP E93, MAP FDAARGOS_305 and MAP E1 strain. Similar deletions were also noticed at nt420-421, nt447-448, nt470-471 for MAP K10, MAP/TANUVAS and MAP JII while Indian Bison CIRG strain featured no such deletions. Similar 4 nucleotide insertion sequence was observed in nt382-386 for MAP K10, MAP/TANUVAS, MAP JII which is not observed in other compared sequences.

The sequence map for MAP 2168c secretome gene showed multiple mutations including nucleotide deletions of ‘TGGCG’, ‘CCGCC’ observed between nt36-40, nt71-75 respectively in MAP bison CIRG, MAP 4, MAP E93, MAP FDAARGOS_305 and MAP E1 while the same was absent in MAP K10, MAP/TANUVAS, MAP JII. Similarly, more such deletions viz., ‘AATT’, ‘AATT’, ‘GGCGG’ and ‘CGCCA’ were also observed at nt126-129, nt360-363, nt414-418, nt449-453 positions, respectively with the same pattern.

While the picture for MAP Mod D secretome gene showed seven major deletions in MAP Indian bison CIRG, MAP 4, MAP E93, MAP FDAARGOS_305, MAP E1 at nt355-357, nt369-372, nt416-421, nt445-452, nt542-544, nt608-613, nt634-636, respectively. The deletions were absent in MAP K10, MAP Indian bison CIRG, MAP/ TANUVAS and MAP JII strain for the MAP MOD D secretome gene.

In MAP 85c, four sequence (CGCC) deletion was observed at position nt70-73 in MAP K10, MAP/TANUVAS and MAP JII strain while Indian Bison CIRG strain does not showed the deletion. Similarly, four sequence (GGCG) deletions was observed at nt123-126 in MAP bison CIRG, MAP 4, MAP E93, MAP FDAARGOS_305 and MAP E1 while the same was absent in MAP K10, MAP/TANUVAS, MAP JII . Interestingly 5 nucleotide sequences (nt259-263) present in MAP K10, MAP/TANUVAS and MAP JII was not observed in Indian bison CIRG, MAP 4, MAP E93, MAP FDAARGOS_305 and MAP E1 strain. Similar 4 nucleotide insertion sequence was observed in nt345-350 for MAP K10, MAP/TANUVAS, MAP JII which is not observed in other compared sequences.

According to the sequence plot of MAP Pep AN secretome gene comparison with the standard reference MAP strains, there was one major deletion (GGTGCCGC) observed at nt25-32 position in MAP K10, MAP Indian Bison CIRG, MAP TANUVAS and MAP JII strains while MAP 4, MAP E93, MAP FDAARGOS_305 and MAP E1 strain does not show this deletion. On contrast the sequence ‘GCGGCACC’ observed at nt405-412 position in MAP K10, MAP Indian bison CIRG, MAP/TANUVAS and MAP JII strain was found it deleted in MAP 4, MAP E93, MAP FDAARGOS and MAP E1 strain.

Three major deletions and two major insertions were observed for the secretome gene MAP Pep ACN . Major deletion observed included nt17-20, nt328-331, nt425-427 positions for MAP K10, MAP Indian bison CIRG, MAP/TANUVAS and MAP JII strain, whereas the other compared strains did not show such deletions. There are 2 major insertions observed at nt405-412 and nt437-439 positions for MAP K10, MAP Indian bison CIRG, MAP/TANUVAS, MAP JII which is not observed in other compared sequences.

Phylogenetic tree analysis

Phylogenetic tree analysis was conducted using minimum evolution method completed by using neighbor joining algorithm for secretome of MAP 1693c, MAP 2168c, MAP Mod D, MAP 85c, MAP Pep AN, MAP Pep ACN (Supplementary Figures 2-7). For 1693c , there are two major branches with the MAP ‘S5’ Indian bison CIRG strain present as an out group of the first branch grouped along with other taxa such as MAP FDAARGOS_305, MAP E1, MAP E93 and MAP 4 , while MAP K10, MAP/TANUVAS and MAP JII were grouped in a separate branch (Figure 3). Similar picture was also observed for phylogenetic tree of secretome gene 2168c where, MAP ‘S5’ Indian bison CIRG strain is present as an outgroup of the first branch associated with other strains such as MAP 4, MAP E-93, MAP E1 and MAP FDAARGOS_305 grouped together in same branch but diverged into separate subclades (Figure 3). Interestingly for MAP Mod D secretome gene, Indian bison CIRG type was present together with MAP K10, MAP/TANUVAS, MAP JII, while MAP E93, MAP E1, MAP 4 and MAP_FDAARGOS_305 strain are present in a different branch of the tree with MAP E93 as an out group of that branch (Figure 3). For secretome MAP 85C , there are two different branches with CIRG strain present as an out group of the first branch while MAP K10, MAP/TANUVAS, MAP JII are present as a separate branch (Figure 3). MAP Pep AN showed as similar picture along the lines of Mod D with CIRG strain group together in the first branch along with MAP K10, MAP JII, MAP/TANUVAS while the second branch featured the other compared strain (MAP 4, MAP E93, MAP FDAARGOS_305 and MAP E1) (Figure 3). The phylogenetic tree for MAP Pep ACN showed an extra branch among all the secretome genes analyzed with two outgroups. With the first group been MAP Indian bison CIRG strain and second MAP/TANUVAS . The first branch has two clades with the first clade comprised MAP FDAARGOS_305, MAP E1, MAP E93 and MAP 4 and the second clade with MAP K10 and MAP JII (Figure 4).

mycobacterial-diseases-Indian-Bison

Figure 3: Evolutionary relationships of taxa for CFP genes viz., MAP1693c, MAP2168c, MAP 85C, MAP ModD and MAP PepAN of various MAP species including the MAP Indian Bison CIRG strain.

mycobacterial-diseases-relationships-taxa

Figure 4: Evolutionary relationships of taxa for MAP Pep AC gene of various MAP species including the MAP Indian Bison CIRG strains.

Discussion

Nucleotide composition in the ORF of MAP 1693c secretome showed variations between the strains compared including Indian bison CIRG, MAP K10, MAP/TANUVAS, MAP 4, MAP E93, MAP FDAARGOS_305, MAP JII-1961 and MAP E1 standard reference stain. Nucleotide (nt) deletions (CCACC) were found in MAP K10, MAP/TANUVAS, MAP JII-1961 at nucleotide position 100 to 104 and another deletion (AGA) between positions nt154 to156 in MAP K10, MAP/TANUVAS and MAP JII-1961 while no deletion in Indian Bison CIRG, MAP 4, MAP E93, MAP FDAARGOS_305 and MAP E1 strain. To the best of our knowledge, there were no known previous studies available to compare and further analyze these mutations and its effect on the function of MAP1693c secretome. MAP 1693c is a Peptidylprolyl cis-trans isomerase (PpiA) which catalyses the interconversion of cis-trans peptide bonds and can accelerate protein folding, with implications in cell surface recognition. The increased role of PpiA in the pathogenic process, and its potential to alter cell surface recognition, makes cue that this protein may be involved in stealth, evading the immune response [37]. MAP 1693c secreted protein has a molecular weight of 18.3 kDa and conserved in MAP having unknown localization [38]. The function of MAP1693c was analyzed using the mutant strain WAg915 (M. avium subsp. paratuberculosis ΔppiA), defective in the peptidyl-prolyl cis-trans-isomerase, showed a mild attenuated phenotype relative to the wild-type strain and resulted in limited tissue colonization following challenge with parental M. avium subsp. paratuberculosis strain [39]. Later, a study reported that MAP 1693c protein specific antisera with their cognate native MAP protein in CF by immune-blotting and ELISA. MAP1693c showed higher specificity (>88%), and is more significant (P<0.05) in infected than uninfected bovine sera samples by immune-blotting. As per data generated during his study, he suggested that MAP1693c contain epitope capable of sensitive detection, and antigen-specific rat antisera data imply that these epitopes may be pathogen-specific. Leroy et al. [40] found MAP1693c were both specific and antigenic. Since there is no concrete information or research findings unequivocally describing the function of MAP1693c secretome is available, the function needs to be explored based on the structural similarity it carries with the other known proteins or by full-proof gene knock out studies on the lines of O’Garra et al. [39].

ORF of MAP 2168c secretome showed variations in nucleotide composition compared including Indian bison CIRG, MAP K10, MAP/TANUVAS, MAP 4, MAP E93, MAP FDAARGOS_305, MAP JII-1961 and MAP E1 standard reference stain. The sequence of MAP 2168c secretome gene showed multiple mutations including nucleotide deletions of ‘TGGCG’, ‘CCGCC’, ‘AATT’, ‘AATT’, ‘GGCGG’ and ‘CGCCA’ at nucleotide position 36-40, 71-75, 361-363, 414-419 and 449-453, respectively in MAP bison CIRG, MAP 4, MAP E93, MAP FDAARGOS_305, MAP JII and MAP E1 while absent in MAP K10, MAP/TANUVAS, MAP JII. There were no known previous studies available to compare and further analyze these mutations and its effect on the function of MAP 2168c secretome. MAP 2168c is a hypothetical protein of 15.9 kDa MW having unknown functions and localization. Cho et al. [24] used Rabbit anti-CF antibodies produced significantly higher ELISA A450 values (p<0.05) with 5 (1693c, 2168c, ModD, 85C, PepA-C) of the 14 recombinant proteins than was seen with the negative control protein (bovine fibronectin). The recombinant protein MAP2168c showed the highest specificity for M. paratuberculosis yielding high ELISA A450 values with rabbit anti-M. paratuberculosis CF and low ELISA A450 values with rabbit anti-M. avium CF. Again, the function of this secretome needs to studied to understand its function and role in virulence or pathogenicity or immunogenicity. To the best of our knowledge, there is no literature available to compare the possible effects of the reported mutations during the study.

Nucleotide composition in ORF of MAP ModD secretome exhibited variations between Indian bison CIRG, MAP K10, MAP/TANUVAS, MAP 4, MAP E93, MAP FDAARGOS_305, MAP JII-1961 and MAP E1 standard reference stain. The sequence in MAP ModD ORF showed seven major deletions in MAP Indian bison CIRG, MAP 4, MAP E93, MAP FDAARGOS_305, MAP E1 at 355-357, 369-372, 416-421, 445-452, 542-544, 608-613, 634-636 nucleotide positions, respectively. The deletions were absent in MAP K10, MAP Indian bison CIRG, MAP/TANUVAS and MAP JII strain for the MAP ModD secretome gene. Mycobacterial ModD is an alanine and proline-rich secretory protein, with an expected size of 45-47-kDa MW possessing immunogenic glycoprotein belonging to fibronectin attachment protein (FAP) family present in several species [41-43] and is conserved in several mycobacterial species including M. tuberculosis, M. bovis , M. vaccae , M. avium , and M. leprae [44]. The ModD homologue was investigated as a dominant secreted antigen of M. tuberculosis and M. Bovis and mycobacteria containing phagosomes [45]. Zhao et al. [46] reported that fibronectin binding peptides blocked the in vitro binding of fibronectin with M. avium . This indicated that M. avium binds with fibronectin with FAPS present on its surface. Middleton et al. [47] demonstrated that addition of recombinant FAP to human respiratory tract organ cultures inhibited the binding of M. avium with extracellular matrix (ECM). They further demonstrated that FAP knock-mutants of M. smegmatis failed to bind with ECM which was restored when a plasmid carrying multicopy FAP gene was transformed into mutant. Secott et al. [48] demonstrated that the fibronectin binding was pH dependent and could be enhanced by acid treatment. They found that MAP contained coding sequences for FAP homologue that bound fibronectin in a FAP dependent manner and bound with M cells. FAPs are important for internalization and invasion of epithelial cells by MAP, and deletion of this gene leads to enhanced aggregation in M. smegmatis [49].

Structural proteomics of ModD has also been evaluated by previous works, which shows MAP ModD proteins were mainly composed of beta sheets. Functional antigenic analysis showed strong antigenicity in ModD due to residues 1-250 possessing high antigenic index when analyzed using protean tool of DNAstar. It has been reported that the fibronectin attachment protein of MAP induces CD4+ and CD8+ T cell activation through TLR-mediated DC activation [50,51]. Presence of ModD in association with MHC class II molecules in late endosomal/ lysomal compartments suggests that it may be processed and presented in association with MHC class II molecules. The major deletions that were observed in the coding region of the ModD suggests potential alteration in the invasive capability of the MAP. This also cues a possible increase or decrease in the virulence of the strains and genotypes reported from India. As in this case, the mutations obtained for MAP S5 Indian Bison type needs further experiments to connect them with virulence capabilities.

Nucleotide composition of ORF of MAP 85c exhibited variations between Indian bison CIRG, MAP K10, MAP/TANUVAS, MAP 4, MAP E93, MAP FDAARGOS_305, MAP JII-1961 and MAP E1 standard reference stain, there was four sequence deletion at nt70-73 nucleotide position in MAP K10, MAP/TANUVAS and MAP JII strain while this deletion was absent in Indian Bison CIRG. Similarly five nucleotide sequence deletion at nt259-263 observed at in MAP K10, MAP/TANUVAS and MAP JII strain which was not deleted in Indian Bison CIRG. While, 4 nucleotide insertion sequence at nt345-350 featured in MAP K10, MAP/TANUVAS, MAP JII was not observed in Indian bison CIRG. The Ag85 complex is a 30-32 kDa family of three proteins (Ag85A, Ag85B) which have mycolyl transferase activity [52] and play a major role in bacterial cell wall synthesis [53], each of which possesses an enzymatic mycolyl-transferase activity required for the biogenesis of cord factor (trehalose-dimycolate) [54,55]. In previous works [56], the role of 85C in the transfer of mycolates have been assessed by inactivation of the gene coding for antigen 85C by transposon mutagenesis. The resulting mutant was shown to transfer 40% fewer mycolates to the cell wall with no change in the types of mycolates esterifying arabinogalactan or in the composition of noncovalently linked mycolates. As a consequence, the diffusion of the hydrophobic chenodeoxycholate and the hydrophilic glycerol, but not that of isoniazid, was found to be much faster through the cell envelope of the mutant than that of the parent strain. Taken together, these data demonstrate that: (i) antigen 85C is involved directly or indirectly in the transfer of mycolates onto the cell wall of the whole bacterium; (ii) the enzyme is not specific for a given type of mycolate; and (iii) the cell wall-linked mycolate layer may represent a barrier for the diffusion of small hydrophobic and hydrophilic molecules. This confirms that these enzymes play a critical role in physiology and pathogenesis of M. tuberculosis [57].

The proteins are encoded by three paralogous genes (fbpA, fbpB and fbpC) located in distinct regions of the bacterial genome [58]. The genes encoding the three Ag85 components from MAP have been sequenced, and at the protein level, a 99% sequence identity with M. avium was found, with a single amino acid residue difference for each protein, isoleucine/threonine in position 284 of the mature Ag85C protein in MAP and M. avium , respectively. Comparisons have also been made between the mature protein sequences of MAP Ag85 and M. bovis Ag85. For the 85C protein (MAP 3531c) 87% of amino acid sequences are identical between MAP and M. bovis [54].

Ag85C (294 aa) were synthesized as 20-mer peptides overlapping by 10 residues, with the exception of two 18-mer peptides (aa 31 to 50 and 41 to 60, residues 33 and 34 lacking in Ag85C) and the carboxyterminal 14-mer peptide (aa 281 to 294). MAP FbpC2 (Ag85C2) is important for the covalent attachment of mycolic acids to arabinogalactan [59]. The recent crystal structure of FbpC2 has revealed a catalytic triad, formed by Ser124, Glu228 and His260, a hydrophobic pocket and tunnel corresponding to a probable TMM binding site, and a trehalose binding site [60,61]. A number of conserved residues among FbpC2 highlighted potential site (s) for interaction with human fibronectin was found [62].

Response against synthetic peptides from Ag85C were much lower. As the Ag85C homologues from M. avium subspecies paratuberculosis and M. Tuberculosis share the highest percentage of identical amino acids, this suggests that low responsiveness to the Ag85C component is probably caused by low expression levels, rather than by low immunogenicity. Low response levels to the Ag85C component have also been described in tuberculosis [63]. MAP 85C induce a strong Th1 response and confer protection against MAP infection [64,65].

The current study could map some of the differences in the coding regions of the Indian Bison type of MAP. Despite this, there might also be variations between global strains and genotypes of MAP, which needs to be explored. The valid point that could leverage this exercise is to study the variations in the MAP85C secretome protein synthesized by various genotypes vis-à-vis their antigenicity and potential marker for their differentiation. Besides, the cord factor associated with wide range of MAP genotypes can be analyzed for applicability in marker assisted DIVA assays.

The nucleotide composition of ORF of MAP Pep AN secretome gene having variations between Indian bison CIRG, MAP K10, MAP/ TANUVAS, MAP 4, MAP E93, MAP FDAARGOS_305, MAP JII-1961 and MAP E1 standard reference stain. There was one major deletion (GGTGCCGC) observed at 25-32 nucleotide position in MAP Indian Bison CIRG, MAP K10, MAP TANUVAS and MAP JII strains while MAP 4, MAP E93, MAP FDAARGOS_305 and MAP E1 strain does not show this deletion. On contrast the eight nucleotide sequence ‘GCGGCACC’ insertion was observed at nt405-412 position in MAP Indian bison CIRG, MAP K10, MAP/ TANUVAS and MAP JII strain but deleted in MAP 4, MAP E93, MAP FDAARGOS and MAP E1 strain.

Three major deletions and two major insertions were observed for the secretome gene MAP Pep ACN . Major deletion observed included nt17-20, 328-331, 425-427 positions for MAP K10, MAP Indian bison CIRG, MAP/TANUVAS and MAP JII strain, whereas the other compared strains did not show such deletions. Major insertions observed included nt405-412 and nt437-439 positions for MAP K10, MAP Indian bison CIRG, MAP/TANUVAS, MAP JII which is absent in other compared sequences. But the current mutations need to be validated with multiple sequencing of MAP strains from the same geographical region encountering clinical Johne’s disease. Moreover, the functional analogy of these insertions and deletions in the coding region would unravel the MAP genotypes evolution under the Indian perspective.

MAP PepA is a serine protease and has a putative signal sequence at the N-terminus. Native PepA was significantly more antigenic in infected sheep, goats, and deer [66], and PepA is conserved among Mycobacterium spp. for example a virulent H37Ra strain, virulent Erdman strain, H37Rv strain, and clinical isolate CSU93 with 100% identity [42]. The antigenicity and diagnostic sensitivity of PepA and ModD was evaluated in patients with Crohn’s disease (CD). It was found that, CD patient sera were found to contain antibodies to ModD and PepA. Interestingly, these two proteins are also highly reactive with sera from cattle with paratuberculosis and are known to be secreted or exported proteins of M. tuberculosis [67]. Native ModD and PepA had a significantly higher diagnostic sensitivity than the recombinant forms of these proteins.

Conclusion

Diagnosis of MAP in larger population requires robust techniques and antigen candidates for eradication studies. DIVA strategy is inevitable in such cases. Secretomes or CFPs produced by MAP could form an excellent candidate for detection of infected animals among the vaccinated herd. The sequence analysis of 6 secretome genes were studied extensively for their genetic composition, mutations and other variations in their open reading frames. Good percentage of homology has been found among the global strains of the MAP along with the Indian Bison type and other Indian isolates. However, certains insertions, deletions within the gene needs to be explored to identify the nature of the disease its dynamics in Indian scenario. These mutations can lead to modulations in the functions of the MAP metabolism thereby influencing the virulence and the host response to the disease.

Acknowledgements

The authors are thankful to the Director, CIRG, Makhdoom, Mathura for providing necessary facilities; Dr. Naveen Kumar (Senior Scientist), NRCE, Hisar for scientific contributions. We are also thankful to ICMR Project, ICMR, New Delhi for providing funds for this work.

Funding Information

Indian Council of Medical Research [grant number 5/8/5/28/TF/ 2013/ECD-I].

Conflict of Interest

The authors declare that they have no conflict of Interest.

References

  1. Singh SV, Singh PK, Singh AV, Sohal JS, Kumar N, et al. (2014) Bio-load and bio-type profiles of Mycobacterium avium subspecies paratuberculosis infection in the farm and farmer’s herds/flocks of domestic livestock: A 28 years study (1985-2013) in India. Transbound Emerg Dis 61: 43-55.
  2. Singh SV, Kumar N, Sohal JS, Singh AV, Singh PK, et al. (2014) First mass screening of the human population to estimate the bio-load of Mycobacterium avium subspecies paratuberculosis in North India. J Biol Sci 14: 237-247.
  3. Chaubey KK, Singh SV, Gupta S, Jayaraman S, Singh M, et al. (2015) Diagnostic potential of three antigens from geographically different regions of the world for the diagnosis of Ovine Johne’s disease in India. Asian J Anim Vet Adv 10: 567-576.
  4. Chaubey KK, Gupta RD, Gupta S, Singh SV, Bhatia AK, et al. (2016) Trends and advances in the diagnosis and control of paratuberculosis in domestic livestock. Vet Q 36: 203-227.
  5. Chaubey KK, Singh SV, Gupta S, Singh M, Sohal JS, et al. (2017) Mycobacterium avium subspecies paratuberculosis- an important food borne pathogen of high public health significance with special reference to India: an update. Vet Q 37: 282-299.
  6. Brzezinski A (2011) Medical management of the patient with an ostomy. In: Lichtenstein GR, Scherl EJ (eds) Crohn’s Disease: the Complete Guide to Medical Management. (1stedn), Slack Incorporated, pp. 417-423.
  7. Naser SA, Sagramsingh SR, Naser AS, Thanigachalam S (2014) Mycobacterium avium subspecies paratuberculosis causes Crohn's disease in some inflammatory bowel disease patients. World J Gastroenterol 20: 7403-7415.
  8. McNees AL, Markesich D, Zayyani NR, Graham DY (2015) Mycobacterium paratuberculosis as a cause of Crohn’s disease. Expert Rev Gastroenterol Hepatol 9: 1523-1534.
  9. Singh AV, Singh SV, Makharia GK, Singh PK, Sohal JS (2008) Presence and characterization of Mycobacterium avium subspecies paratuberculosis from clinical and suspected cases of Crohn’s disease and in the healthy human population in India. Int J Infect Dis 12: 190-197.
  10. Singh AV, Singh SV, Singh PK, Sohal JS, Singh MK (2011) High prevalence of Mycobacterium avium subspecies paratuberculosis (‘Indian bison type’) in animal attendants suffering from gastrointestinal complaints who work with goat herds endemic for Johne’s disease in India. Int J Infect Dis 5: e677-683.
  11. Sohal JS, Sheoran N, Narayanasamy K, Brahmachari V, Singh S, et al. (2009) Genomic analysis of local isolate of Mycobacterium avium subspecies paratuberculosis. Vet Microbiol 134: 375-382.
  12. Singh SV, Kuenstner JT, Davis WC, Agarwal P, Kumar N, et al. (2016) Concurrent cure of Crohn’s disease and infection with Mycobacterium avium paratuberculosis. Frontiers in Medicine 3: 1-5.
  13. Turenne CY, Wallace R, Behr MA (2007) Mycobacterium aviumin the postgenomic era. Clin Microbiol Rev 20: 205-229.
  14. Cosma CL, Sherman DR, Ramakrishnan L (2003) The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol 57: 641-676.
  15. De Jonge MI, Pehau-Arnaudet G, Fretz MM, Romain F, Bottai D, et al. (2007) ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol 189: 6028-6034.
  16. Li LL, Bannantine JP, Zhang Q, Amonsin A, May BJ, et al. (2005) The complete genome sequence of Mycobacterium avium subspecies paratuberculosis. Proc Natl Acad Sci USA 102: 12344-12349.
  17. Rastogi N, Legrand E, Sola C (2001) The mycobacteria: An introduction to nomenclature and pathogenesis. Rev Sci Tech Office Int Epiz 20: 21-54.
  18. Singh SV, Kumar N, Singh SN, Bhattacharya T, Sohal JS, et al. (2013) Genome Sequence of the “Indian Bison Type” Biotype of Mycobacterium avium subsp. paratuberculosis Strain S5. Genome Announc 1: e00005-13.
  19. Stinear TP, Seemann T, Harrison PF, Jenkin GA, Davies JK, et al. (2008) Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res 18: 729-741.
  20. Sohal JS, Singh SV, Singh PK, Singh AV (2010) On the evolution of “Indian bison type” strains of Mycobacterium avium subspecies paratuberculosis. Microbiol Res 165: 163-171.
  21. Singh SV, Singh AV, Singh PK, Gupta VK, Kumar S, et al. (2007) Sero-prevalence of paratuberculosis in young kids using ‘Bison type’, Mycobacterium avium subsp. paratuberculosis antigen in plate ELISA. Small Rumin Res 70: 89-92.
  22. Singh SV (2015) Development and characterization of indigenous vaccine and diagnostics for Johne’s disease. CSIR NMITLI final report. Central Institute for Research on Goats, Makhdoom, Mathura, UP, India.
  23. Cho D, Collins MT (2006) Comparison of the proteosomes and antigenicities of secreted and cellular proteins produced by mycobacterium paratuberculosis. Clin Vaccine Immunol 13: 1155-1161.
  24. Cho D, Shin SJ, Talaat AM, Collins MT (2007) Cloning, expression, purification and serodiagnostic evaluation of fourteen Mycobacterium paratuberculosisproteins. Protein Expr Purif 53: 411-420.
  25. Cho DH, Sung N, Collins MT (2006) Identification of proteins of potential diagnostic value for bovine paratuberculosis. Proteomics 6: 5785-5794.
  26. Samanich KM, Keen MA, Vissa VD, Harder JD, Spencer JS, et al. (2000) Serodiagnostic potential of culture filtrate antigens of Mycobacterium tuberculosis. Clin Diagn Lab Immunol 7: 662-668.
  27. Waters WR, Palmer MV, Thacker TC, Bannantine JP, Vordermeier HM, et al. (2006) Early antibody responses to experimental Mycobacterium bovis infection of cattle Clin Vaccine Immunol 13: 648-654.
  28. Bannantine JP, Bayles DO, Waters WR, Palmer MV, Stabel JR, et al. (2008) Early antibody response against Mycobacterium avium subspecies paratuberculosis antigens in subclinical cattle. Proteome Science 6: 1-12.
  29. Wadhwa A, Hickling GJ, Eda S (2012) Opportunities for improved serodiagnosis of human tuberculosis, bovine tuberculosis, and paratuberculosis. Vet Med Int 2012: 1-13.
  30. Shin SJ, Cho D, Collins MT (2008) Diagnosis of bovine paratuberculosis by a novel enzyme-linked immunosorbent assay based on early secreted antigens of Mycobacterium avium subsp. Paratuberculosis. Clin Vaccine Immunol 15: 1277-1281.
  31. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30: 2725-2729.
  32. Rzhetsky A, Nei M (1992) A simple method for estimating and testing minimum.evolution trees. Mol Biol Evol 9: 945-967.
  33. Felsenstein J (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39: 783-791.
  34. Tamura K, Nei M, Kumar S (2004) Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA 101: 11030-11035.
  35. Nei M and Kumar S (2000) Molecular Evolution and Phylogenetics. Oxford University Press, New York.
  36. Saitou N, Nei M (1987) The neighbor-joining method: A new method for reconstructingphylogenetic trees. Mol Biol Evol 9: 406-425.
  37. Hughes V, Smith S, Garcia-Sanchez A, Sales J, Stevenson K (2007) Proteomic comparison of Mycobacterium avium subspecies paratuberculosis grown in vitro and isolated from clinical cases of ovine paratuberculosis. Microbiol 153: 196-205.
  38. Mon M, Viale M, Baschetti G, Pinedo FA, Gioffre A, et al. (2012) Search for Mycobacterium avium subspecies paratuberculosis antigens for the diagnosis of paratuberculosis. Vet Med Int 2012: 1-9.
  39. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, et al. (2013) The immune response in tuberculosis. Annu. Rev. Immunol. 31: 475-527.
  40. Leroy B, Roupie V, Noel-Georis I, Rosseels V, Walravens K (2007) Antigen discovery: a postgenomic approach to paratuberculosis diagnosis. Proteomics 7: 1164-1176.
  41. Romain F, Laqueyrerie A, Militzer P, Pescher P, Chavarot P, et al. (1993) Identification of Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infect Immunol 61: 742-750.
  42. Ratliff TL, McCarthy R, Telle WB, Brown EJ (1993) Purification of a mycobacterial adhesin for fibronectin. Infect Immun 61: 1889-1894.
  43. Schorey JS, Holsti MA, Ratli TL, Allen PM, Brown EJ (1996) Characterization of the fibronectin-attachment proteinof Mycobacterium avium reveals a fibronectin-binding motifconserved among mycobacteria. Mol Microbiol 21: 321-329.
  44. Laqueyrerie A., Militzer P, Romain F, Eiglmeier K, Cole S (1995) Cloning, sequencing, and expression of the apa gene coding for the Mycobacterum tuberculosis 45/47-kilodalton secreted antigen complex. Infect Immunol 63: 4003-4010.
  45. Beatty WL and Russell DG (2000) Identification of mycobac-terial surface proteins released into subcellular compartments of infected macrophages. Infect Immun 68: 6997-7002
  46. Zhao W, Schorey JS, Groger R, Allen PM, Brown EJ, et al. (1999) Characterization of the fibronectin bindingmotif for a unique mycobacterial fibronectin attachment protein FAP. J Biol Chem 274: 4521-4526.
  47. Middleton AM, Chadwick MV, Nicholson AG, Dewar A, Groger RK (2000). The role of M. avium complex fibronectin attachment protein In adherence to the human respiratory mucosa. Mol Microbiol 38: 381-391.
  48. Secott TE, Lin TL, Wu CC (2001) Fibronectin attachment protein homologue mediates fibronectin binding by Mycobacterium avium subsp. paratuberculosis. Infect Immun 69: 2075-2082
  49. Yuji Miyamoto, Tetsu Mukai, Fumihiko Takeshita, Noboru Nakata, Yumi Maeda, et al. (2004) Aggregation of mycobacteria caused by disruption offibronectin-attachment protein-encoding gene. FEMS Microbiol Lett 236: 227-234.
  50. Lee JS, Shin SJ, Collins MT, Jung ID, Jeong YI, et al. (2009) Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein activates dendritic cells and induces a Th1 polarization. Infect Immun 77: 2979-2988.
  51. Noh KT, Shin SJ, Son KH, Jung ID, Kang HK, et al. (2012) The Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein, a toll-like receptor 4 agonist, enhances dendritic cell-based cancer vaccine potency. Exp Mol Med 44: 340-349.
  52. Wiker HG, Harboe M (1992) The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol Rev 56: 648-661.
  53. Aghababa H, Mobarez AM, Behmanesh M, Khoramabadi N, Mobarhan M (2011) Production and Purification of Mycolyl Transferase B of Mycobacterium tuberculosis. Tanaffos 10: 23-30.
  54. Dheenadhayalan V, Shin KS, Chang CF, Chang CD, Wang SJ, et al. (2002) Cloning and characterization of the genes coding for antigen 85A, 85B and 85C of Mycobacterium avium subsp. paratuberculosis. DNA Seq. 13: 287-294.
  55. Ronning DR, Vissa V, Besra GS, Belisle JT, Sacchettini JC (2004) Mycobacterium tuberculosis Antigen 85A and 85C Structures Confirm Binding Orientation and Conserved Substrate Specificity. J Biol Chem 279: 36771-36777.
  56. Jackson M, Raynaud C, Laneelle MA, Guilhot C, Laurent-Winter C, et al. (1999) Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol 31: 1573-1587.
  57. Sanki AK, Boucau J, Ronning DR, Sucheck SJ (2009) Antigen 85Cmediated acyl-transfer between synthetic acyl donors and fragments of the arabinan. Glycoconj J 26: 589-96.
  58. Content J, Cuvellerie A de La, Wit L De, Vincent-Levy-Frebault V, Ooms J, et al. (1991) The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun 59: 3205-3212.
  59. Jackson M, Raynaud C, Laneelle MA, Guilhot C, Laurent-Winter C, et al. (2000) Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol Microbiol 31: 1573-1587.
  60. Ronning DR, Klabunde T, Besra GS, Vissa VD, Belisle JT, et al. (2000) Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nat Struct Biol 7: 141-146.
  61. Anderson DH, Harth G, Horwitz MA, Eisenberg D (2001) An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase. J Mol Biol 307: 671-681.
  62. Naito M, Ohara N, Matsumoto S, Yamada T (1998) The novel fibronectin-binding motif and key residues of mycobacteria. J Biol Chem 273: 2905-2909.
  63. Vale´rie Rosseels, Sylvie Marche, Virginie Roupie, Marc Govaerts, Jacques Godfroid, et al. (2006) Members of the 30- to 32-Kilodalton Mycolyl Transferase Family (Ag85) from Culture Filtrate of Mycobacterium avium subsp. paratuberculosis are Immunodominant Th1-Type Antigens Recognized Early upon Infection in Mice and Cattle. Infect Immun 74: 202-212.
  64. Kathaperumal K, Park SU, McDonough S, Stehman S, Akey B, et al. (2008) Vaccination with recombinant Mycobacterium aviumsubsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge. Vaccine 26: 1652-1663.
  65. Shin SJ, Chang CF, Chang CD, McDonough SP, Thompson B, et al. (2005) In vitro cellular immune responses to recombinant antigens of Mycobacterium avium subsp. paratuberculosis. Infect Immun 73: 5074-5085.
  66. Cameron RM, Stevenson K, Inglis NS, Klausen J, Sharp JM (1994) Identification and characterization of a putative serine protease expressed in vivo by Mycobacterium avium subsp. paratuberculosis. Microbiol 140: 1977-1982.
  67. Braunstein M, Espinosa BJ, Chan J, Belisle JT, Jacobs WR Jr (2003) SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol Microbiol 48: 453-464.
Citation: Singh SV, Chaubey KK, Kumaresan G, Gupta RD, Bhatia AK, et al. (2018) Molecular Diversity and Homology in Six CFPs Genes in the Novel Bio-Type, 'Indian Bison Type' of Mycobacterium avium subspecies paratuberculosis of Goat Origin vs. other Biotypes. Mycobact Dis 8:267.

Copyright: © 2018 Singh SV, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top